Cargando…

Congenital adrenal hyperplasia due to two rare CYP21A2 variant alleles, including a novel attenuated CYP21A1P/CYP21A2 chimera

BACKGROUND: Congenital adrenal hyperplasia (CAH) due to 21‐hydroxylase (21OH) deficiency is an autosomal recessive inborn error of cortisol biosynthesis, with varying degrees of aldosterone production. There is a continuum of phenotypes which generally correlate with genotype and the expected residu...

Descripción completa

Detalles Bibliográficos
Autores principales:	Lao, Qizong, Burkardt, Deepika D., Kollender, Sarah, Faucz, Fabio R., Merke, Deborah P.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2023
Materias:	Clinical Reports
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10337281/ https://www.ncbi.nlm.nih.gov/pubmed/37157918 http://dx.doi.org/10.1002/mgg3.2195

Ejemplares similares

Molecular genetic testing of congenital adrenal hyperplasia due to 21-hydroxylase deficiency should include CAH-X chimeras
por: Lao, Qizong, et al.
Publicado: (2021)

Novel variants of CYP21A2 in Vietnamese patients with congenital adrenal hyperplasia
por: Chi, Dung V., et al.
Publicado: (2019)

Variant predictions in congenital adrenal hyperplasia caused by mutations in CYP21A2
por: Prado, Mayara J., et al.
Publicado: (2022)

Dual Heterozygous Mutations in CYP21A2 and CYP11B1 in a Case of Nonclassic Congenital Adrenal Hyperplasia
por: Frontera, Eric D., et al.
Publicado: (2022)

Molecular genetic analysis of CYP21A2 gene in patients with congenital adrenal hyperplasia
por: Marumudi, Eunice, et al.
Publicado: (2012)

Molecular Diagnosis of Congenital Adrenal Hyperplasia in Iran: Focusing on CYP21A2 Gene
por: Rabbani, Bahareh, et al.
Publicado: (2011)

CYP21A2 mutations in pediatric patients with congenital adrenal hyperplasia in Costa Rica
por: Umaña-Calderón, Andrés, et al.
Publicado: (2021)

A new CYP21A1P/CYP21A2 chimeric gene identified in an Italian woman suffering from classical congenital adrenal hyperplasia form
por: Concolino, Paola, et al.
Publicado: (2009)

PSAT047 Dual Heterozygous Mutations in CYP21A2 and CYP11B1 in a Case of Nonclassic Congenital Adrenal Hyperplasia
por: Frontera, Eric, et al.
Publicado: (2022)

CYP21A2 Gene Mutations in Congenital Adrenal Hyperplasia: Genotype−phenotype correlation in Turkish children
por: Baş, Firdevs, et al.
Publicado: (2009)

Mutation detection of CYP21A2 gene in nonclassical congenital adrenal hyperplasia patients with premature pubarche
por: Kolahdouz, Mahsa, et al.
Publicado: (2016)

Molecular Analysis of CYP21A2 Gene Mutations among Iraqi Patients with Congenital Adrenal Hyperplasia
por: Al-Obaidi, Ruqayah G. Y., et al.
Publicado: (2016)

Functional studies of novel CYP21A2 mutations detected in Norwegian patients with congenital adrenal hyperplasia
por: Brønstad, Ingeborg, et al.
Publicado: (2014)

SUN-204 Case of Non-Classic Congenital Adrenal Hyperplasia with Compound CYP21A2 Mutations Combined with CYP11B1 Mutation
por: Salameh, Rami, et al.
Publicado: (2020)

Comprehensive Genetic Testing of CYP21A2: A Retrospective Analysis in Patients with Suspected Congenital Adrenal Hyperplasia
por: Nan, Madalina Nicoleta, et al.
Publicado: (2021)

SAT275 Generation And Characterization Of A Humanized CYP21A2 Mouse Model For Congenital Adrenal Hyperplasia
por: Huebner, Angela, et al.
Publicado: (2023)

Mutation spectrum of CYP21A2 and correlation between genotype – phenotype in 81 Vietnamese patients with congenital adrenal hyperplasia due to 21-hydroxylase defficiency
por: Dung, Vu Chi, et al.
Publicado: (2013)

Novel method to characterize CYP21A2 in Florida patients with congenital adrenal hyperplasia and commercially available cell lines
por: Greene, Christopher N., et al.
Publicado: (2014)

OR25-01 Durable CYP21A2 Gene Therapy in Non-Human Primates for Treatment of Congenital Adrenal Hyperplasia
por: Eclov, Rachel J, et al.
Publicado: (2020)

The Spectrum of CYP21A2 Gene Mutations from 16 Families of Congenital Adrenal Hyperplasia: Genotype-Phenotype Correlation
por: Sridhar, Subbiah, et al.
Publicado: (2021)

Premature Moustache As Presenting Symptom of Nonclassic Congenital Adrenal Hyperplasia due to 2 Uncommon Mutations of the CYP21A2 Gene
por: Massa, Guy, et al.
Publicado: (2011)

A CYP21A2 gene mutation in patients with congenital adrenal hyperplasia: Molecular genetics report from Saudi Arabia
por: Mohamed, Sarar, et al.
Publicado: (2015)

Novel deletion alleles carrying CYP21A1P/A2 chimeric genes in Brazilian patients with 21-hydroxylase deficiency
por: Coeli, Fernanda B, et al.
Publicado: (2010)

Clinical profile and inheritance pattern of CYP21A2 gene mutations in patients with classical congenital adrenal hyperplasia from 10 families
por: Yadav, Sarita, et al.
Publicado: (2015)

Co-existence of Congenital Adrenal Hyperplasia and Familial Hypokalemic Periodic Paralysis due to CYP21A2 and SCN4A Pathogenic Variants
por: Kontbay, Tuğba, et al.
Publicado: (2021)

Inhibitory Potency of 8-Methoxypsoralen on Cytochrome P450 2A6 (CYP2A6) Allelic Variants CYP2A6*15, CYP2A6*16, CYP2A6*21 and CYP2A6*22: Differential Susceptibility Due to Different Sequence Locations of the Mutations
por: Tiong, Kai Hung, et al.
Publicado: (2014)

Phenotypic variability of hyperandrogenemia in females heterozygous for CYP21A2 mutations
por: Neocleous, Vassos, et al.
Publicado: (2014)

The pathogenic p.Gln319Ter variant is not causing congenital adrenal hyperplasia when inherited in one of the duplicated CYP21A2 genes
por: Fanis, Pavlos, et al.
Publicado: (2023)

Salt-wasting congenital adrenal hyperplasia phenotype as a result of the TNXA/TNXB chimera 1 (CAH-X CH-1) and the pathogenic IVS2-13A/C > G in CYP21A2 gene
por: Fanis, Pavlos, et al.
Publicado: (2022)

Compound heterozygosity for a whole gene deletion and p.R124C mutation in CYP21A2 causing nonclassic congenital adrenal hyperplasia
por: Nasir, Hamza, et al.
Publicado: (2018)

A TNXB splice donor site variant as a cause of hypermobility type Ehlers–Danlos syndrome in patients with congenital adrenal hyperplasia
por: Lao, Qizong, et al.
Publicado: (2020)

H62L Mutation of CYP21A2 Identified in the Non-classical Form of 21-Hydroxylase Deficiency
por: Nagasaki, Keisuke, et al.
Publicado: (2009)

Direct Molecular Diagnosis of CYP21A2 Point Mutations in Macedonian and Serbian Patients with 21-Hydroxylase Deficiency
por: Anastasovska, Violeta, et al.
Publicado: (2015)

Data on the 21-Hydroxylase deficient CAH patients and the identification of known/novel mutations in CYP21A2 gene
por: Khajuria, Ragini, et al.
Publicado: (2016)

C4B null alleles are not associated with genetic polymorphisms in the adjacent gene CYP21A2 in autism
por: Sweeten, Thayne L, et al.
Publicado: (2008)

Variations in the 3′UTR of the CYP21A2 Gene in Heterozygous Females with Hyperandrogenaemia
por: Neocleous, Vassos, et al.
Publicado: (2017)

Characterization of Mutations Causing CYP21A2 Deficiency in Brazilian and Portuguese Populations
por: Prado, Mayara J., et al.
Publicado: (2021)

Pregnanetriol in the Range of 1.2–2.1 mg/m(2)/day as an Index of Optimal Control in CYP21A2 Deficiency
por: Izawa, Masako, et al.
Publicado: (2007)

The Associations of Androgen-Related Genes CYP21A2 and CYP19A1 with Severe Acne Vulgaris in Patients from Southwest China
por: Yang, Ting, et al.
Publicado: (2021)

CYP21A2 Gene Expression in a Humanized 21-Hydroxylase Mouse Model Does Not Affect Adrenocortical Morphology and Function
por: Schubert, Tina, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_er82hgdlopjblnva38208qeemb